As of Tuesday, December 16, Corcept Therapeutics Incorporated’s CORT share price has dipped by 6.98%, which has investors ...

Cort has expanded its G Series of affordable electric guitars with the G250 SE, an HSS bolt-on S-style that offers a heap of versatility – and some eye-catching specs – for just $349. We are big fans ...

What Happened? Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 4.7% in the afternoon session after ...

Relacorilant, developed by Corcept Therapeutics (NASDAQ: CORT), is a selective glucocorticoid receptor (GR) antagonist designed to control hypercortisolism symptoms in endogenous Cushing's syndrome.

Corcept has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock ...

Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the best multibagger stocks to invest in right now. The company has recently revised its 2025 revenue guidance to $850-$900 million, down from the ...

The strong range of features that accompany this sonic capability, offered at this price (£549/€635/$TBC), is why we think Cort has issued another strong claim to ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 2, Corcept Therapeutics Incorporated (NASDAQ:CORT) announced ...

Cort has added three shreddable new electric guitars to its KX series, with a pair of multi-scale 7-string guitars joining a generously spec’d KX700 EverTune. The release comes hot on the heels of ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Every year or so, Bud Cort gets a check in the mail for something like $11. The money is all he earns for having played a lead role in the beloved 1971 film "Harold and Maude." Cort says his paltry ...